Information:
Error:
Keywords
Disease Response ×
- Clinical Trial (96)
- Lymphoma, Non-Hodgkin (23)
- Hematology (14)
- Lung Neoplasms (9)
- Physical Examination (8)
- Radioimmunotherapy (7)
- Pancreatic Neoplasms (7)
- Laboratories (6)
- Medical Oncology (6)
- Breast Neoplasms (5)
- Anemia, Aplastic (5)
- Multiple Myeloma (5)
- Clinical Chemistry Tests (4)
- Response Elements (4)
- Leukemia, Myelomonocytic, Juvenile (4)
- Leukemia (4)
- Antibodies (4)
- Myelodysplastic Syndromes (4)
- Pregnancy Tests (3)
- Prostatic Neoplasms (3)
- Radiology (3)
- Sarcoma, Kaposi (3)
- Urinalysis (3)
- Blood Coagulation (3)
- Vital Signs (3)
- Adverse event (3)
- Electrocardiogram (ECG) (3)
- Compliance (3)
- Electrolytes (3)
- Neuroblastoma (3)
- Colorectal Neoplasms (2)
- Biological Markers (2)
- Lymphoma, B-Cell (2)
- Central Nervous System Neoplasms (2)
- Brain Neoplasms (2)
- Consensus (2)
- Bone metastasis (2)
- Follow-Up Studies (2)
- HIV (2)
- Lymphoma (2)
- Waldenstrom Macroglobulinemia (2)
- Anus Neoplasms (2)
- Rectal Neoplasms (1)
- Sarcoma, Ewing (1)
- Leukemia, Myeloid, Chronic-Phase (1)
- Drugs, Investigational (1)
- Endometrial Neoplasms (1)
- Biopsy (1)
- Clinical Trial, Phase II (1)
- Clinical Trial, Phase III (1)
- Topotecan (1)
- Burkitt Lymphoma (1)
- Carcinoma (1)
- Adenocarcinoma (1)
- Gastrointestinal Stromal Tumors (1)
- Uterine Cervical Neoplasms (1)
- Consolidation Chemotherapy (1)
- Cisplatin (1)
- Dermatology (1)
- Drug Therapy (1)
- Esophagus (1)
- Hodgkin Disease (1)
- Amyloidosis (1)
- Immunotherapy (1)
- Kidney Neoplasms (1)
- Melanoma (1)
- Neoplasm Staging (1)
- Neoplasms, Germ Cell and Embryonal (1)
- Pathology (1)
Table of contents
Selected data models
You must log in to select data models for download or further analysis.
103 Search results.
Itemgroups: Central Pathology Assessment,Pathology Assessment Description,Administration
Itemgroups: Header,Period Number,Tumor Response,Comments,CCRR MODULE
Itemgroups: VIDE Response,Primary tumor,Metastasis
Itemgroups: EXTENT OF DISEASE-Identification,EXTENT OF DISEASE-Evaluations,COMMENTS
Itemgroups: Header Module,Clinical Assessment,Notice of Recurrence,COMMENTS
Itemgroups: Adiminstrative Daten I,Geburtsdatum,Adiminstrative Daten II,Transplantationspatient,Rezidiv,Patient ist verstorben,Patient lebt,Gründe für vorzeitiges Ausscheiden aus der Studie,Unterschrift
Itemgroups: Header Module,Unnamed 1,Footer Module
Itemgroups: Administrative,Laboratory Results (Week 3-13, 25) - Hematology,Laboratory Results (Week 3-13, 25) - Hematology,Laboratory Results (Week 25) - Hematology ,Laboratory Results (Week 3, 13, 25) - Chemistry,Laboratory Results (Week 3 and 13) - Chemistry,Laboratory Results (Week 7) - Chemistry,Laboratory Results (Week 7) - Chemistry ,Laboratory Results (Week 25) - Chemistry ,Physical Examination (Week 7, 13, 25),Physical Examination (Week 7, 13, 25),Post-Treatment Response (Week 7, 13, 25) - CT or other Radiological Imaging Results,Post-Treatment Response (Week 7, 13, 25) - Bone Marrow Biopsy,Post-Treatment Response (Week 7 and 13) - Received medication/transfusion,Post-Treatment Response (Week 7, 13, 25) - Measurable Lymphoma Disease,Post-Treatment Response (Week 7, 13, 25) - Non-Measurable Lymphoma Disease,Post-Treatment Response (Week 7, 13, 25) - Non-Measurable Lymphoma Disease,Post-Treatment Response (Week 7, 13, 25) - Response,Signature of Investigator
GSK Ofatumumab in Waldenstrom Macroglobulinaemia, NCT00811733 - Response Evaluation and Confirmation
Itemgroups: Administrative Data,Response Evaluation,Complete Response Confirmation
Itemgroups: Administrative,Best overall response assessment,New tumor biopsy/ sample
Itemgroups: Administrative documentation,TNM clinical staging,Rectal Carcinoma, Pathological staging,Rectal Carcinoma, Sphincter, Preservation technique
Itemgroups: Administrative data,Investigational Product,Drug Dose,Tumor Measurements,Best Tumor Response,Pre-treatment Hematologies and Chemistries